For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before ...

For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before symptoms appear, a new study indicates. Idiopathic REM sleep behavior disorder ...

A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; ...

Researchers at McGill University found that a blood test originally designed for Alzheimer’s can predict dementia risk in ...

CervoMed (CRVO) announced results from the first 16 weeks of the extension phase of the Phase 2b RewinD-LB study of neflamapimod in the ...

CervoMed (Nasdaq: CRVO) has announced encouraging findings from the first 16 weeks of the extension phase of its Phase IIb ...

CervoMed has announced positive results from the extension phase 2b RewinD-LB study of neflamapimod for dementia with Lewy ...

Explore the spectrum of dementia, its causes, and how it impacts cognitive health, with insights into care strategies and ...

CervoMed's neflamapimod capsules show increased efficacy in treating dementia with Lewy bodies, with promising safety results and lower fall incidence. The new capsules led to higher plasma ...

Hospice use varies depending on whether a person has Parkinson’s disease, Lewy body dementia or Alzheimer’s disease and those with Parkinson’s may have more unmet needs, a new study finds.

Positive 16-week extension data from Cervomed Inc.’s phase IIb in dementia with Lewy bodies followed a failure from December. New results from the Rewind-LB trial testing neflamapimod, a ...